市場調查報告書
商品編碼
1466635
膜氧供應市場:按類型、年齡層、應用分類 - 2024-2030 年全球預測Membrane Oxygenators Market by Type (Flat Sheet Membrane Oxygenators, Hollow Fiber Membrane Oxygenators), Age Group (Adults, Neonates, Pediatrics), Application - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
膜氧供應市場規模預計2023年為6.1584億美元,2024年達到6.5981億美元,預計2030年將達到9.6762億美元,複合年成長率為6.66%。
膜氧合器是體外膜氧合 (ECMO) 系統的關鍵組成部分,該系統透過為患者體外的血液充氧來提供長期的心臟和呼吸支持。膜式供氧市場是指醫療設備業中以膜式供氧系統的設計、製造和銷售為主的市場。膜式氧合器市場的成長受到多種因素的影響,例如呼吸系統疾病的增加、技術進步以及全球 ECMO 中心的增加。此外,更容易患慢性病的人口老化和醫療基礎設施的改善也促進了成長。政府改善先進醫療保健機會的舉措正在推動市場的進一步成長。然而,ECMO 程序和相關設備的高成本可能會限制資源匱乏地區的市場准入。圍繞治療的複雜性、對醫護人員進行專門培訓的需要以及出血和感染等併發症的風險的擔憂也對市場成長構成了挑戰。旨在提高 ECMO 治療效率和減少併發症的技術創新正在吸引市場機會。用於監控制氧機性能的感測器整合以及用於即時資料分析和患者管理的智慧技術的引入在未來幾年也有成長潛力。
主要市場統計 | |
---|---|
基準年[2023] | 61584萬美元 |
預測年份 [2024] | 65981萬美元 |
預測年份 [2030] | 9.6762億美元 |
複合年成長率(%) | 6.66% |
類型: 偏好增加
平板膜氧合器是一種用於體外膜氧合(ECMO)系統的氣體交換裝置。平板膜氧合器使用平板膜促進氧氣進入血液並排放血液中的二氧化碳。平板膜氧合器在某些臨床環境中是首選,因為它們的初始體積較小,可以最大限度地減少填充氧合器所需的血液量,使它們適合新生兒和兒童患者。另一方面,中空纖維膜供氧裝置由一束微孔中空纖維組成,血液透過中空纖維流到外面,並穿過半透膜進行氣體交換。中空纖維膜氧合器因其高效的氣體交換和比平板式氧合器更低的阻力而被成人 ECMO 廣泛首選。
應用:在心臟病領域的多種應用,提供體外循環和供氧
在心臟應用領域,膜氧合器對於在心臟直視手術和其他心血管手術期間需要支援的患者非常重要。膜氧合器提供體外循環和血液氧合,確保重要器官在暫時心臟驟停期間受到保護。心包氧合器需要滿足性能標準,例如高氣體交換能力、低壓降、低預衝量和生物相容性,以最大限度地降低血液凝固和溶血的風險。在體外心肺復甦術 (ECPR) 中,當傳統心肺復甦術 (CPR) 無效時,膜氧合器在為心臟麻痹患者提供救生措施方面發揮著至關重要的作用。 ECPR 氧合器必須快速輸送氧氣,以防止組織缺氧並支持血流動力學,直到心臟功能穩定。膜式氧合器的呼吸應用主要針對對傳統機械通氣無反應的嚴重呼吸衰竭患者。薄膜氧合器的任務是去除二氧化碳並提供長期氧氣供應,為急性呼吸窘迫症候群(ARDS) 和慢性呼吸道疾病提供長期支援。
區域洞察
由於醫療基礎設施的改善以及心血管和呼吸系統疾病的高發病率,美洲,特別是美國和加拿大對膜氧合設備的需求強勁。由於心肺體外迴圈手術的技術創新和COPD(慢性阻塞性肺病)盛行率的上升,美洲地區的市場正在進一步擴大。歐洲國家對病人安全和嚴格遵守衛生法規表現出了堅定的承諾,從而導致更多地採用高品質標準和高技術合規性。人口老化、嚴格的法規和政府資助的醫療保健系統等因素正在增加歐洲地區對膜氧合設備的需求。受醫療基礎設施開拓和政府醫療支出增加的影響,中東和非洲正逐漸成為膜式氧合器的新興市場,特別是在波灣合作理事會(GCC)國家。在亞太地區,中國、印度和日本由於人口眾多、醫療改革取得進展以及衛生基礎設施投資而不斷成為重要國家。中國的專利活動反映出對膜式氧合器的成本效益和可擴展製造流程的關注。日本是一個注重技術和品質的成熟市場,而印度是一個快速成長的市場,呼吸系統疾病和心臟病的盛行率不斷上升。然而,負擔能力和可用性是亞太地區的關鍵促進因素,導致對價格敏感的購買行為和對具有成本效益的產品的需求。
FPNV定位矩陣
FPNV定位矩陣對於評估膜氧合裝置市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對膜氧設備市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,以獲得市場競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4.競爭力評估及資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.膜式供氧裝置市場規模及預測如何?
2.膜供氧市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些?
3.膜氧供應市場的技術趨勢和法規結構是什麼?
4.膜式供氧裝置市場主要廠商的市場佔有率是多少?
5.進入膜氧供應市場的合適形式和策略手段是什麼?
[184 Pages Report] The Membrane Oxygenators Market size was estimated at USD 615.84 million in 2023 and expected to reach USD 659.81 million in 2024, at a CAGR 6.66% to reach USD 967.62 million by 2030.
The membrane oxygenator devices are critical components in extracorporeal membrane oxygenation (ECMO) systems, which provide prolonged cardiac and respiratory support by oxygenating a patient's blood outside the body. The membrane oxygenators market refers to the space within the medical devices industry focused on designing, manufacturing, and selling membrane oxygenators. Several factors, such as increasing prevalence of respiratory diseases, technological advancements, and an increase in the number of ECMO centers globally influence the growth of the membrane oxygenators market. Additionally, an aging population susceptible to chronic diseases and improvements in healthcare infrastructure have contributed positively to the expansion. Government initiatives to improve access to advanced healthcare treatments provide further growth impetus for the market. However, the high cost of ECMO procedures and associated equipment can restrict market accessibility in resource-constrained settings. Concerns surrounding the complexity of the treatment, the need for specialized training for healthcare providers, and the risk of complications such as bleeding and infection also pose challenges for market growth. Moreover, technological innovations aimed at increasing efficiency and reducing complications associated with ECMO treatment are attracting opportunities in the market. Integrating sensors to monitor oxygenator performance and incorporating smart technologies for real-time data analysis and patient management also has growth potential in upcoming years.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 615.84 million |
Estimated Year [2024] | USD 659.81 million |
Forecast Year [2030] | USD 967.62 million |
CAGR (%) | 6.66% |
Type: Increasing preference for flat sheet membrane oxygenators due to low prime volume
Flat sheet membrane oxygenators are a type of gas exchange device used in extracorporeal membrane oxygenation (ECMO) systems. Flat sheet membrane oxygenators employ flat sheet membranes that facilitate the transfer of oxygen into and carbon dioxide out of the blood. Flat sheet membrane oxygenators are often preferred in specific clinical environments due to their low prime volume, which minimizes the amount of blood required to fill the oxygenator, making them suitable for neonatal and pediatric patients. However, hollow fiber membrane oxygenators consist of bundles of microporous hollow fibers through which blood flows externally, and gas exchange occurs across the semipermeable membrane. Hollow fiber membrane oxygenators are widely preferred for adult ECMO due to their efficient gas exchange capabilities and lower resistance compared to flat sheet models.
Application: Diverse applications in cardiac disorders to provide extracorporeal circulation and oxygenation
In the cardiac application segment, membrane oxygenators are critical for patients who require support during open-heart surgery and other cardiovascular procedures. Membrane oxygenators provide extracorporeal circulation and oxygenation of the blood, ensuring vital organs are protected while the heart is temporarily stopped. The performance criteria that determine the preference for a cardiac membrane oxygenator include high gas exchange capacity, low pressure drop, low priming volume, and biocompatibility to minimize the risk of blood clotting and hemolysis. For Extracorporeal Cardiopulmonary Resuscitation (ECPR), membrane oxygenators play a quintessential role in providing life-saving measures for patients in cardiac arrest when conventional CPR is ineffective. ECPR oxygenators must rapidly deliver oxygenation to prevent tissue hypoxia and support hemodynamics until the heart function can be stabilized. Respiratory applications of membrane oxygenators are mainly for patients with severe respiratory failure, unresponsive to conventional mechanical ventilatory support. Membrane oxygenators are tasked with removing CO2 and providing oxygenation over prolonged periods, often in the context of Acute Respiratory Distress Syndrome (ARDS) or for long-term support in chronic respiratory conditions.
Regional Insights
In the Americas, particularly in the United States and Canada, there is a robust demand for membrane oxygenators owing to a well-established healthcare infrastructure and high incidence of cardiovascular and respiratory diseases. Innovations in cardiopulmonary bypass surgery techniques and the rising prevalence of COPD (Chronic Obstructive Pulmonary Disease) further enhance the market in the Americas region. European countries show a deep commitment to patient safety and rigorous adherence to health regulations, leading to the rising adoption of high-quality standards and the implementation of advanced technology compliances. Factors such as an aging population, stringent regulations, and government-funded healthcare systems drive the need for membrane oxygenators in the European region. The Middle East and Africa are gradually emerging markets for membrane oxygenators, influenced by the development of healthcare infrastructure and increased healthcare expenditure by governments, particularly in the Gulf Cooperation Council (GCC) countries. China, India, and Japan have emerged as significant countries in the Asia-Pacific region due to its large population base, increasing healthcare reforms, and investment in healthcare infrastructure. The patent activity in China reflects a focus on cost-effective and scalable manufacturing processes for membrane oxygenators. Japan offers a mature market with emphasis on technology and quality and India is a fast-growing market, with rising prevalence of respiratory and cardiac diseases. However, affordability and accessibility are key drivers in the APAC region, leading to price-sensitive purchasing behavior and a need for cost-effective products.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Membrane Oxygenators Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Membrane Oxygenators Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Membrane Oxygenators Market, highlighting leading vendors and their innovative profiles. These include Alpha Plan GmbH, Braile Biomedica, Chalice Medical Ltd., Cytosorbents Corporation, Elite Lifecare, EUROSETS S.r.l., Fresenius SE & Co KGaA, Gen World Medical Devices, Getinge AB, Harvard Apparatus, Inc., LivaNova PLC, MC3 Cardiopulmonary, Medihub Sciencetec Private Limited, Medtronic PLC, Microport Scientific Corporation, Nipro Corporation, Owgels Group, Senko Medical Instrument Mfg. Co., Ltd., Shandong Wego New Life Medical Devices Co.,Ltd., Terumo Corporation, and Xenios AG by Fresenius Medical Care AG & Co. KGaA.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Membrane Oxygenators Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Membrane Oxygenators Market?
3. What are the technology trends and regulatory frameworks in the Membrane Oxygenators Market?
4. What is the market share of the leading vendors in the Membrane Oxygenators Market?
5. Which modes and strategic moves are suitable for entering the Membrane Oxygenators Market?